This insulin switches into the veins around the gut then into the liver acting much like a normal pancreas would. As the insulin lowers the glucose level in the physical body, the gel reacts by hardening and stopping the supply again. This means that a regulator is had by the device in place that will not allow over or under dose. The device is in its pre-clinical testing stage now. When finally accepted, it will be implanted between your lowest rib and the hip and topped up with insulin every couple of weeks. Victoria King, head of study at the charity Diabetes UK, stated that the implant could have advantages over long-term insulin pumps, which require users to test their blood glucose levels frequently..Bayer has excellent development perspectives – because of its outstanding knowledge in R&D and advertising, its dynamic technology pipeline, its solid brands and an excellent existence in the Emerging Marketplaces. Bayer: Science For AN IMPROVED Existence Bayer is a worldwide enterprise with primary competencies in the areas of healthcare, agriculture and high-tech polymer components. As an innovation organization, it sets styles in research-intensive areas. Simultaneously, the Group aims to create value through creativity, growth and high generating power. Bayer is focused on the concepts of sustainable development also to its public and ethical obligations as a corporate citizen. In fiscal 2014, the combined group employed 118,900 people and experienced sales of EUR 42.2 billion.